Latest research: After infection with Omikon, it is impossible to immune to Omikon's variants

Jimu News reporter Huang Jiaqi

Can I effectively improve the immunity of the future infection with Omikon after the infection? On June 17, the latest research from the Chinese team showed that the earliest version of the new version of the new crown virus Omikon varieties, even if the vaccine has been vaccinated, may be infected with the later version of Omikon variants.

On June 17, Chinese researchers from research teams from Peking University published research papers in the "Nature" magazine. Studies showed that patients who had been infected with Omikon BA.1 in vaccination Virus and the initial SARS-COV-2 virus (severe acute respiratory syndrome-coronary virus-2, which causes new coronary pneumonia) antibodies, but the Omikon subtypes that are now spread are mutated, so that it can avoid These antibodies.

Chinese researchers published research papers in "Nature" (picture source "Nature" magazine official website)

Researchers found in the experiment that these new Omikon subtypes "obviously avoided the neutral antibody caused by SARS-COV-2 infection and vaccination."

This explains why breakthrough infections and repetitive infections are common phenomena in the mutant strains of Omikon.

Earlier, the European Centers for Disease Control and Prevention said on June 13 that the two new sub -variants BA.4/5 of the new crown virus mutant strain Omikon is beyond other poisons in Europe, which will become the leading poison in Europe. The strain. This trend has also been confirmed in other countries.

According to Reuters on June 18, at present, most of the infection in the United States was Omikon BA.2.12.1. In addition, Omikon BA.5 and BA.4 also accounted for more than 21%of new cases. This means that people who have been infected with Omikon may still be infected with new variants again.

Dr. Ogba Aguro, a infectious disease researcher at Yale University School of Medicine, said: "Although inoculation of Omikon's specific vaccine may have some advantages, I think it will only have marginal benefits compared to existing vaccines and enhanced agents. "

However, Ogbaugu said: "Although there are immune defects, the vaccine will still prevent serious diseases. If you need to vaccinate the enhanced agent, then inoculate. , To keep the blood circulation high -level new coronal virus antibody. "

The microbiology and infectious disease researchers of the Ikan Medical College of Sinai Medical College of New York City, Aduf Garcia Saster, suggested that using vaccines for a variety of virus strains or internal vaccines that can increase infection may obtain better protection Essence

- END -